Robust prognostic biomarkers and a risk prediction model specific to EGFR-mutated lung adenocarcinoma patients via multicohort meta-analysis

Background: Epidermal growth factor receptor (EGFR) mutation is a key therapeutic target and clinical predictive biomarker for lung adenocarcinoma. However, few prognostic biomarkers and risk prediction models for EGFR-mutated patients exist due to small sample sizes and heterogeneous cancer mechani...

Full description

Saved in:
Bibliographic Details
Main Authors: Haangik Park, Yejin Kim, Hwiin Jo, Myeong-Ha Hwang, Hyojin Son, Sechan Lee, Gwan-Su Yi
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S240584402501388X
Tags: Add Tag
No Tags, Be the first to tag this record!